Address: Edifício Berrini 500 Praça Profº José Lannes, 40 – 15º andar Cidade Monções – São Paulo – SP Cep: 04571-100,Brazil
Tel: 0800 166 575
Web: http://www.zodiac.com.br/
Founded in 1991, Zodiac Pharmaceuticals is a partner of advanced research laboratories in the area of?health in various countries and encourages the development of new therapeutic approaches. Attention to technological development and innovations in the pharmaceutical industry provides excellence in the company’s product lines.
With a focus on quality control, Zodiac has a factory in Pindamonhangaba, São Paulo, supported by cutting edge technology that allows you to meet local needs and exports. This infrastructure facilitates the process from various industrial products, from raw material to finished product. All these factors, combined with social projects and a solid human resources policy, ensure that Zodiac Pharmaceuticals is committed to the standard of excellence in all its departments.
Founded in 1991, Zodiac Pharmaceuticals is a partner of advanced research laboratories in the area of?health in various countries and encourages the development of new therapeutic approaches. Attention to technological development and innovations in the pharmaceutical industry provides excellence in the company’s product lines.
With a focus on quality control, Zodiac has a factory in Pindamonhangaba, São Paulo, supported by cutting edge technology that allows you to meet local needs and exports. This infrastructure facilitates the process from various industrial products, from raw material to finished product. All these factors, combined with social projects and a solid human resources policy, ensure that Zodiac Pharmaceuticals is committed to the standard of excellence in all its departments.
What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical industry needs to improve its R&D capabilities. I personally think…
Lauro Moretto, Emeritus President of the Brazilian Academy of Pharmaceutical Sciences and former Executive Vice-President of Sindusfarma provides insights into the main changes that have impacted Brazil’s pharmaceutical field over…
In an exclusive interview, Jarbas Barbosa da Silva, Director-President of the Brazilian Health Regulatory Agency (ANVISA), discusses some of the key specificities of the Brazilian market and highlights some of…
Dr. Wilson Pedreira, executive director of the Oncology and Hematology Center of the Albert Einstein Philanthropic Society in Brazil provides insights into the innovative healthcare model implemented in this cutting…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of…
When we interviewed you four years ago, you gave us a picture of the industry. How has that picture changed since then? We can start with the regulatory picture. In…
Hypermarcas is a huge, diversified corporation that sells everything from shampoo, to medicine. Would you consider it more of a consumer goods company that happens to sell pharmaceuticals, or the…
Many readers may find it counterintuitive that SINDUSFARMA, which represents syndicates, is organized by a team of management executives. Historically, these two groups tend to be in opposition. Can you…
What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical industry needs to improve its R&D capabilities. I personally think…
We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret these changes into a…
Minister Pimentel recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
You’ve made some bold moves in your career – from the head of vaccines in Latin America, followed by stints in Colombia, Puerto Rico, and finally Brazil. What brought you…
We asked Mr. Santos regarding his recommendations to help the government innovate, compete, and grow in the pharmaceutical industry here in Brazil on the Human Genetic Therapies side. Is there…
See our Cookie Privacy Policy Here
